Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

International Impact of COVID-19 on the Diagnosis of Heart Disease

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Harvard

Einstein, AJ, Shaw, LJ, Hirschfeld, C, Williams, MC, Villines, TC, Better, N, Vitola, JV, Cerci, R, Dorbala, S, Raggi, P, Choi, AD, Lu, B, Sinitsyn, V, Sergienko, V, Kudo, T, Nørgaard, BL, Maurovich-Horvat, P, Campisi, R, Milan, E, Louw, L, Allam, AH, Bhatia, M, Malkovskiy, E, Goebel, B, Cohen, Y, Randazzo, M, Narula, J, Pascual, TNB, Pynda, Y, Dondi, M, Paez, D, The INCAPS COVID Investigators Group & Kyhl, K 2021, 'International Impact of COVID-19 on the Diagnosis of Heart Disease', Journal of the American College of Cardiology, bind 77, nr. 2, s. 173-185. https://doi.org/10.1016/j.jacc.2020.10.054

APA

Einstein, A. J., Shaw, L. J., Hirschfeld, C., Williams, M. C., Villines, T. C., Better, N., Vitola, J. V., Cerci, R., Dorbala, S., Raggi, P., Choi, A. D., Lu, B., Sinitsyn, V., Sergienko, V., Kudo, T., Nørgaard, B. L., Maurovich-Horvat, P., Campisi, R., Milan, E., ... Kyhl, K. (2021). International Impact of COVID-19 on the Diagnosis of Heart Disease. Journal of the American College of Cardiology, 77(2), 173-185. https://doi.org/10.1016/j.jacc.2020.10.054

CBE

Einstein AJ, Shaw LJ, Hirschfeld C, Williams MC, Villines TC, Better N, Vitola JV, Cerci R, Dorbala S, Raggi P, Choi AD, Lu B, Sinitsyn V, Sergienko V, Kudo T, Nørgaard BL, Maurovich-Horvat P, Campisi R, Milan E, Louw L, Allam AH, Bhatia M, Malkovskiy E, Goebel B, Cohen Y, Randazzo M, Narula J, Pascual TNB, Pynda Y, Dondi M, Paez D, The INCAPS COVID Investigators Group, Kyhl K. 2021. International Impact of COVID-19 on the Diagnosis of Heart Disease. Journal of the American College of Cardiology. 77(2):173-185. https://doi.org/10.1016/j.jacc.2020.10.054

MLA

Vancouver

Einstein AJ, Shaw LJ, Hirschfeld C, Williams MC, Villines TC, Better N o.a. International Impact of COVID-19 on the Diagnosis of Heart Disease. Journal of the American College of Cardiology. 2021 jan. 19;77(2):173-185. https://doi.org/10.1016/j.jacc.2020.10.054

Author

Einstein, Andrew J ; Shaw, Leslee J ; Hirschfeld, Cole ; Williams, Michelle C ; Villines, Todd C ; Better, Nathan ; Vitola, Joao V ; Cerci, Rodrigo ; Dorbala, Sharmila ; Raggi, Paolo ; Choi, Andrew D ; Lu, Bin ; Sinitsyn, Valentin ; Sergienko, Vladimir ; Kudo, Takashi ; Nørgaard, Bjarne Linde ; Maurovich-Horvat, Pál ; Campisi, Roxana ; Milan, Elisa ; Louw, Lizette ; Allam, Adel H ; Bhatia, Mona ; Malkovskiy, Eli ; Goebel, Benjamin ; Cohen, Yosef ; Randazzo, Michael ; Narula, Jagat ; Pascual, Thomas N B ; Pynda, Yaroslav ; Dondi, Maurizio ; Paez, Diana ; The INCAPS COVID Investigators Group ; Kyhl, Kasper . / International Impact of COVID-19 on the Diagnosis of Heart Disease. I: Journal of the American College of Cardiology. 2021 ; Bind 77, Nr. 2. s. 173-185.

Bibtex

@article{bfb3cece600c491ca0a2162e135431c1,
title = "International Impact of COVID-19 on the Diagnosis of Heart Disease",
abstract = "BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified.OBJECTIVES: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices.METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained.RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower-middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth.CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19-related changes in care delivery is warranted.",
keywords = "COVID-19, Diagnostic Techniques, Cardiovascular/statistics & numerical data, Global Health, Health Care Surveys, Heart Diseases/diagnosis, Humans, International Agencies, global health, cardiovascular disease, coronavirus, cardiac testing",
author = "Einstein, {Andrew J} and Shaw, {Leslee J} and Cole Hirschfeld and Williams, {Michelle C} and Villines, {Todd C} and Nathan Better and Vitola, {Joao V} and Rodrigo Cerci and Sharmila Dorbala and Paolo Raggi and Choi, {Andrew D} and Bin Lu and Valentin Sinitsyn and Vladimir Sergienko and Takashi Kudo and N{\o}rgaard, {Bjarne Linde} and P{\'a}l Maurovich-Horvat and Roxana Campisi and Elisa Milan and Lizette Louw and Allam, {Adel H} and Mona Bhatia and Eli Malkovskiy and Benjamin Goebel and Yosef Cohen and Michael Randazzo and Jagat Narula and Pascual, {Thomas N B} and Yaroslav Pynda and Maurizio Dondi and Diana Paez and {The INCAPS COVID Investigators Group} and Kasper Kyhl",
note = "Copyright {\textcopyright} 2021 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = jan,
day = "19",
doi = "10.1016/j.jacc.2020.10.054",
language = "English",
volume = "77",
pages = "173--185",
journal = "American College of Cardiology. Journal",
issn = "0735-1097",
publisher = "Elsevier Inc",
number = "2",

}

RIS

TY - JOUR

T1 - International Impact of COVID-19 on the Diagnosis of Heart Disease

AU - Einstein, Andrew J

AU - Shaw, Leslee J

AU - Hirschfeld, Cole

AU - Williams, Michelle C

AU - Villines, Todd C

AU - Better, Nathan

AU - Vitola, Joao V

AU - Cerci, Rodrigo

AU - Dorbala, Sharmila

AU - Raggi, Paolo

AU - Choi, Andrew D

AU - Lu, Bin

AU - Sinitsyn, Valentin

AU - Sergienko, Vladimir

AU - Kudo, Takashi

AU - Nørgaard, Bjarne Linde

AU - Maurovich-Horvat, Pál

AU - Campisi, Roxana

AU - Milan, Elisa

AU - Louw, Lizette

AU - Allam, Adel H

AU - Bhatia, Mona

AU - Malkovskiy, Eli

AU - Goebel, Benjamin

AU - Cohen, Yosef

AU - Randazzo, Michael

AU - Narula, Jagat

AU - Pascual, Thomas N B

AU - Pynda, Yaroslav

AU - Dondi, Maurizio

AU - Paez, Diana

AU - The INCAPS COVID Investigators Group

A2 - Kyhl, Kasper

N1 - Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2021/1/19

Y1 - 2021/1/19

N2 - BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified.OBJECTIVES: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices.METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained.RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower-middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth.CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19-related changes in care delivery is warranted.

AB - BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified.OBJECTIVES: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices.METHODS: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained.RESULTS: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p < 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower-middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth.CONCLUSIONS: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19-related changes in care delivery is warranted.

KW - COVID-19

KW - Diagnostic Techniques, Cardiovascular/statistics & numerical data

KW - Global Health

KW - Health Care Surveys

KW - Heart Diseases/diagnosis

KW - Humans

KW - International Agencies

KW - global health

KW - cardiovascular disease

KW - coronavirus

KW - cardiac testing

UR - http://www.scopus.com/inward/record.url?scp=85098954230&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2020.10.054

DO - 10.1016/j.jacc.2020.10.054

M3 - Journal article

C2 - 33446311

VL - 77

SP - 173

EP - 185

JO - American College of Cardiology. Journal

JF - American College of Cardiology. Journal

SN - 0735-1097

IS - 2

ER -

ID: 73248603